Have a personal or library account? Click to login
Isolation and cellular properties of mesenchymal stem cells from human periosteum Cover

Isolation and cellular properties of mesenchymal stem cells from human periosteum

Open Access
|Feb 2017

References

  1. 1. Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol. 2004; 32:1212-25.10.1016/j.exphem.2004.09.003
  2. 2. Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol. 2000; 28:875-84.10.1016/S0301-472X(00)00482-3
  3. 3. Devine SM. Mesenchymal stem cells: Will they have a role in the clinic? J Cell Biochem. 2002; 85:73-9.10.1002/jcb.10046
  4. 4. Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, et al. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly. In Vitro Cell Dev Biol Anim. 2012; 48:75-83.10.1007/s11626-011-9480-x
  5. 5. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. PNAS. 2000; 97:3213-8.10.1073/pnas.97.7.3213
  6. 6. Simmons PJ, Gronthos S, Zannettino A, Ohta S, Graves S. Isolation, characterization and functional activity of human marrow stromal progenitors in hemopoiesis. Prog Clin Biol Res. 1994; 389:271-80.
  7. 7. Verfaillie CM, Schwartz R, Reyes M, Jiang Y. Unexpected potential of adult stem cells. Ann N Y Acad Sci. 2003; 996:231-4.10.1111/j.1749-6632.2003.tb03251.x
  8. 8. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002; 99:3838-43.10.1182/blood.V99.10.3838
  9. 9. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002; 30:42-8.10.1016/S0301-472X(01)00769-X
  10. 10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284:143-7.10.1126/science.284.5411.14310102814
  11. 11. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000; 6:1282-6.10.1038/8139511062543
  12. 12. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105:93-8.10.1161/hc0102.101442
  13. 13. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418:41-9.10.1038/nature00870
  14. 14. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, cultureexpanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997; 64:295-312.10.1002/(SICI)1097-4644(199702)64:2<;295::AID-JCB12>3.0.CO;2-I
  15. 15. Long MW. Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis. 2001; 27:677-90.10.1006/bcmd.2001.0431
  16. 16. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res. 1998; 355:S247-56.10.1097/00003086-199810001-00025
  17. 17. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999; 5:309-13.10.1038/6529
  18. 18. Horwitz EM, Prockop DJ, Gordon PL, et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood. 2001; 97: 1227-31.10.1182/blood.V97.5.1227
  19. 19. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002; 30:215-22.10.1038/sj.bmt.1703650
  20. 20. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000; 18: 307-16.10.1200/JCO.2000.18.2.307
  21. 21. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. The Lancet. 2004; 363:1439-41.10.1016/S0140-6736(04)16104-7
  22. 22. Aicher WK, Bü­hring H-J, Hart M, Rolauffs B, Badke A, Klein G. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells- Potential and pitfalls. Adv Drug Deliv Rev. 2011; 63: 342-51.10.1016/j.addr.2010.12.004
  23. 23. Hutmacher DW, Sittinger M. Periosteal cells in bone tissue engineering. Tissue Engineering. 2003; 9:45-64.10.1089/10763270360696978
  24. 24. Netter, Frank H. Musculoskeletal system: anatomy, physiology, and metabolic disorders. New Jersey: Ciba-Geigy Corporation; 1987.
  25. 25. Kasten P, Luginbühl R, Van Griensven M, Barkhausen T, Krettek C, Bohner M, et al. Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, â-tricalcium phosphate and demineralized bone matrix. Biomaterials. 2003; 24: 2593-603.10.1016/S0142-9612(03)00062-0
  26. 26. Van PT, Vignery A, Baron R. Cellular kinetics of the bone remodeling sequence in the rat. Anat Rec (Hoboken). 1982; 202:445-51.10.1002/ar.1092020403
  27. 27. Meyer U, Joos U, Wiesmann H. Biological and biophysical principles in extracorporal bone tissue engineering: Part I. Int J Oral Maxillofac Surg. 2004; 33:325-32.10.1016/S0901-5027(03)00199-1
  28. 28. Schantz JT, Hutmacher DW, Chim H, Ng KW, Lim TC, Teoh SH. Induction of ectopic bone formation by using human periosteal cells in combination with a novel scaffold technology. Cell Transplant. 2002; 11: 125-38.10.3727/096020198389852
  29. 29. Roberts SJ, Geris L, Kerckhofs G, Desmet E, Schrooten J, Luyten FP. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials. 2011; 32:4393-405.10.1016/j.biomaterials.2011.02.04721421268
  30. 30. Eyckmans J, Luyten FP. Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Engineering. 2006; 12:2203-13.10.1089/ten.2006.12.220316968161
  31. 31. Gargett CE, Schwab KE, Zillwood RM, Nguyen HPT, Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium.
  32. Biol Reprod. 2009; 80:1136-45.19228591
DOI: https://doi.org/10.5372/1905-7415.0706.240 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 777 - 785
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Thakoon Thitiset, Supranee Buranapraditkul, Siriporn Damrongsakkul, Sittisak Honsawek, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.